Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MADRIGAL PHARMACEUTICALS, INC.

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL)
Listen to this Section

$536.05
-0.6500 ( -0.12% ) 0.3K

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Market Data
Open $536.05
Previous Close $536.70
Volume 0.3K
Market Cap $12.37B
Day Range $536.48 - $536.48
52 Week Range $286.44 - $615.00
Shares Outstanding 23.06M
Change % -0.12%
Net Change ▼ -0.6500
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2007
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 2,814.00

Date Type Amount Purchased Purchaser
2025-08-20 Buy 177.00 BAKER BROS. ADVISORS LP
2025-08-20 Buy 2460.00 BAKER BROS. ADVISORS LP
2025-08-20 Buy 177.00 BAKER BROS. ADVISORS LP

SEC Filings

Form Type Description Pages Date
4 Insider transactions 1 Jul 18, 2025
4 Insider transactions 1 Jul 18, 2025

Latest News

About US

Services

Stay Connected